Relief Cardiovascular
Innovative closed loop transcatheter implant revolutionizing congestive heart failure treatment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $12.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Relief Cardiovascular is pioneering a groundbreaking closed loop transcatheter implant designed to transform the treatment of congestive heart failure. This innovative medical device aims to improve patient outcomes by offering a more efficient and effective solution for managing this chronic condition. Relief Cardiovascular primarily serves healthcare providers and patients suffering from congestive heart failure, operating within the medical device market. The company's business model revolves around the development, manufacturing, and distribution of its proprietary implant, generating revenue through direct sales to hospitals and clinics, as well as partnerships with healthcare organizations.
Keywords: congestive heart failure, transcatheter implant, medical device, healthcare, innovation, patient outcomes, chronic condition, healthcare providers, manufacturing, distribution.